Evidence map›Paper›PMID 31777174›Full record

ArticleMolecular systems biology2019

Temporal perturbation of ERK dynamics reveals network architecture of FGF2/MAPK signaling.

Yannick Blum, Jan Mikelson, Maciej Dobrzyński, Hyunryul Ryu, Marc-Antoine Jacques, Noo Li Jeon, Mustafa Khammash, Olivier Pertz

Open access · goldAbstract read
In one paragraph

Article in Molecular systems biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. MAPK/ERK Pathway as a Central Regulator in Vertebrate Organ Regeneration.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yannick BlumInstitute of Cell Biology, University of Bern, Bern, Switzerland.
Jan MikelsonDepartment of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Maciej DobrzyńskiInstitute of Cell Biology, University of Bern, Bern, Switzerland.ORCID 0000-0002-0208-7758
Hyunryul RyuInstitute of Advanced Machinery and Design, Seoul National University, Seoul, Korea.
Marc-Antoine JacquesInstitute of Cell Biology, University of Bern, Bern, Switzerland.
Noo Li JeonInstitute of Advanced Machinery and Design, Seoul National University, Seoul, Korea.
Mustafa KhammashDepartment of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Olivier PertzInstitute of Cell Biology, University of Bern, Bern, Switzerland.ORCID 0000-0001-8579-4919
University of Bern · CHETH Zurich · CHSeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stimulation of PC-12 cells with epidermal (EGF) versus nerve (NGF) growth factors (GFs) biases the distribution between transient and sustained single-cell ERK activity states, and between proliferation and differentiation fates within a cell population. We report that fibroblast GF (FGF2) evokes a distinct behavior that consists of a gradually changing population distribution of transient/sustained ERK signaling states in response to increasing inputs in a dose response. Temporally controlled GF perturbations of MAPK signaling dynamics applied using microfluidics reveal that this wider mix of ERK states emerges through the combination of an intracellular feedback, and competition of FGF2 binding to FGF receptors (FGFRs) and heparan sulfate proteoglycan (HSPG) co-receptors. We show that the latter experimental modality is instructive for model selection using a Bayesian parameter inference. Our results provide novel insights into how different receptor tyrosine kinase (RTK) systems differentially wire the MAPK network to fine-tune fate decisions at the cell population level.

Indexed as

AnimalsBayes TheoremDose-Response Relationship, DrugExtracellular Signal-Regulated MAP KinasesFibroblast Growth Factor 2Heparan Sulfate ProteoglycansMAP Kinase Signaling SystemMicrofluidic Analytical TechniquesPC12 CellsRatsReceptors, Fibroblast Growth FactorExtracellular Signal-Regulated MAP KinasesFibroblast Growth Factor 2Heparan Sulfate ProteoglycansReceptors, Fibroblast Growth Factorcell fate determinationERK signaling dynamicsmechanistic modelingmicrofluidicsparameter estimation

Identifiers

PMID31777174
PMCPMC6864398
OpenAlexW2990700472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.